Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Bortezomib-Dexamethasone, Rituximab, and Cyclophosphamide as First-Line Treatment for Waldenström's Macroglobulinemia: A Prospectively Randomized Trial of the European Consortium for Waldenström's Macroglobulinemia.

Christian Buske,Meletios A Dimopoulos,Alexander Grunenberg,Efstathios Kastritis,Cecile Tomowiak,Béatrice Mahé,Xavier Troussard,Roman Hajek,Andreas Viardot,Olivier Tournilhac,Therese Aurran,Stephane Lepretre,Hacene Zerazhi,Benedicte Hivert,Veronique Leblond,Sophie de Guibert,Lena Brandefors,Ramon Garcia-Sanz,Maria Gomes da Silva,Eva Kimby,Birgit Schmelzle, Dajana Kaszynski,Jens Dreyhaupt,Rainer Muche,Pierre Morel

Journal of clinical oncology : official journal of the American Society of Clinical Oncology（2023）

Cited 12|Views68
No score
Abstract
This large randomized study illustrates that B-DRC is highly effective and well tolerated in WM. The data demonstrate that fixed duration immunochemotherapy remains an important pillar in the clinical management of WM.
More
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined